EDESA BIOTECH INC (EDSA) Stock Analyst Earnings Estimates
NASDAQ:EDSA - Nasdaq - CA27966L3065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 211.9K -7.18% | 410.9K 93.91% | 328.8K -19.98% | -100.00% | |||||||
| EBITDA YoY % growth | -4.89M 3.08% | -2.827M 42.18% | -6.343M -124.36% | -12.24M -271.46% | N/A 22.54% | N/A 50.48% | N/A 24.46% | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.078M 2.80% | -2.832M 44.23% | -6.401M -126.01% | -24.897M -269.97% | -22.338M 22.42% | -9.213M 49.80% | -8.568M 23.94% | -7.242M -3.24% | -14.11M -94.84% | -23.052M -63.37% | |
| Operating Margin | -2,396.55% | -689.24% | -1,946.72% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -7.31 63.92% | -10.25 -332.35% | -4.62 58.50% | -2.65 36.72% | -1.43 26.01% | -2.08 -45.71% | -1.95 6.37% |
All data in USD
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.30 -3.17% | -0.36 25.63% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -1.989M -98.03% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.25 51.92% | -0.27 | 0.02 | 6.92% |
| Q2 2025 Q2Q % growth | -0.30 48.28% | -0.30 | 0.00 | 0.30% |
| Q1 2025 Q2Q % growth | -0.48 11.11% | -0.32 | -0.16 | -51.80% |
| Q4 2024 Q2Q % growth | -0.29 51.67% | -0.55 | 0.26 | 47.35% |
| Q3 2024 Q2Q % growth | -0.52 25.71% | -0.59 | 0.07 | 12.10% |
| Q2 2024 Q2Q % growth | -0.58 30.95% | -0.71 | 0.13 | 17.99% |
| Q1 2024 Q2Q % growth | -0.54 40.66% | -1.23 | 0.69 | 56.25% |
| Q4 2023 Q2Q % growth | -0.60 -328.57% | -0.72 | 0.12 | 16.76% |
| Q3 2023 Q2Q % growth | -0.70 72.97% | -1.24 | 0.54 | 43.44% |
| Q2 2023 Q2Q % growth | -0.84 63.64% | -1.24 | 0.40 | 32.13% |
| Q1 2023 Q2Q % growth | -0.91 60.61% | -1.36 | 0.45 | 32.92% |
| Q4 2022 Q2Q % growth | -0.14 48.15% | -2.82 | 2.68 | 95.04% |
| Q3 2022 Q2Q % growth | -2.59 -619.44% | -3.07 | 0.48 | 15.64% |
| Q2 2022 Q2Q % growth | -2.31 -185.19% | -2.62 | 0.31 | 11.77% |
| Q1 2022 Q2Q % growth | -2.31 -788.46% | -2.86 | 0.55 | 19.12% |
| Q4 2021 Q2Q % growth | -0.27 -22.73% | -0.37 | 0.10 | 27.81% |
| Q3 2021 Q2Q % growth | -0.36 -80.00% | -0.33 | -0.03 | -10.29% |
| Q2 2021 Q2Q % growth | -0.81 -376.47% | -0.30 | -0.51 | -169.19% |
| Q1 2021 Q2Q % growth | -0.26 | -0.19 | -0.07 | -34.16% |
| Q4 2020 Q2Q % growth | -0.22 | -0.21 | -0.01 | -5.21% |
| Q3 2020 Q2Q % growth | -0.20 | -0.21 | 0.01 | 4.35% |
| Q2 2020 Q2Q % growth | -0.17 | -0.19 | 0.02 | 12.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q4 2020 Q2Q % growth | 500 -99.88% | 51K | -50.5K | -99.02% |
| Q3 2020 Q2Q % growth | 110K 21,900.00% | 51K | 59K | 115.69% |
| Q2 2020 Q2Q % growth | 110.5K -6.20% | 51K | 59.5K | 116.67% |
| Q1 2020 Q2Q % growth | 107.8K 103.40% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 9.2% | 10.74% | 0% | -5.66% |
| Revenue | N/A | N/A | N/A | N/A |